Revenue | ₹30.77Cr |
Net Profits | ₹4.70Cr |
Net Profit Margins | 15.27% |
Indo US Bio-Tech Ltd’s revenue jumped 24.32% since last year same period to ₹30.77Cr in the Q1 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -8.15% fall in its revenue since last 3-months.
Indo US Bio-Tech Ltd’s net profit jumped 48.26% since last year same period to ₹4.70Cr in the Q1 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 27.72% jump in its net profits since last 3-months.
Indo US Bio-Tech Ltd’s net profit margin jumped 19.26% since last year same period to 15.27% in the Q1 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 39.05% jumped in its net profit margins since last 3-months.
The revenue for Indo US Bio-Tech Ltd in the Q1 results 2025 was ₹30.77Cr.
The net profit for Indo US Bio-Tech Ltd in the Q1 results 2025 was ₹4.70Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q1 results 2025 was 15.27%.
The revenue for Indo US Bio-Tech Ltd in the Q1 results 2024 was ₹24.75Cr.
The net profit for Indo US Bio-Tech Ltd in the Q1 results 2024 was ₹3.17Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q1 results 2024 was 12.81%.